Vaccinia virus for human gene therapy

Surgical Oncology Clinics of North America

Volumn 7, Issue 3, 1998, Pages 575-588

  Peplinski, G R ^a   Tsung, K ^a   Norton, J A ^a  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 12; VIRUS DNA; VIRUS VECTOR;

ANTINEOPLASTIC ACTIVITY; CANCER THERAPY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN; NONHUMAN; PLASMID; REVIEW; SAFETY; VACCINIA VIRUS; VIRAL GENETICS; VIRUS INFECTIVITY; VIRUS RECOMBINANT;

EID: 0031879520     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1055-3207(18)30261-8     Document Type: Review

References (33)

1. Acres B. Dott K. Stefani L. Directed cytokine expression in tumour cells in vivo using recombinant vaccini virus Therapeutic Immunology 1 1994 17 23
2. Baxby D. Paoletti E. Potential use of non-replicating vectors as recombinant vaccines Vaccine 10 1982 8 9
3. Brochier B. Thomas I. Bauduin B. Use of a vaccinia-rabies recombinant virus for the oral vaccination of foxes against rabies Vaccine 1990 101 104
4. Buller R.M.L. Palumbo G.J. Poxvirus pathogenesis Microbiol Rev 55 1991 80 122
5. Buller R.M.L. Chakrabarti S. Cooper J.A. Deletion of the vaccinia virus growth factor gene reduces virus virulence J Virol 62 1988 866 874
6. Buller R.M.L. Smith G.L. Cremer K. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype Nature 317 1985 813 815
7. Chakrabarti S. Brechling K. Moss B. Vaccinia virus expression vector: Coexpression of beta-galactosidase provides visual screening of recombinant virus plaques Mol Cell Biol 5 1985 3403 3409
8. Chamberlain R.S. Carroll M.W. Bronte V. Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccines Cancer Res 56 1996 2832 2836
9. Child S.J. Palumbo G.F. Buller R.M.L. Insertional inactivation of the large subunit of ribonucleotide reductase encoded by vaccinia virus is associated with reduced virulence in vivo Virology 174 1990 625 629
10. Cochran M.A. Mackett M. Moss B. Eukaryotic transient expression system dependent on transcription factors and regulatory DNA sequences of vaccinia virus Proc Natl Acad Sci U S A 82 1985 19 23
11. Cooney E.L. McElrath M.J. Corey L. Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp 160 protein Proc Natl Acad Sci USA 90 1993 1882 1886
12. Cox W.I. Tartaglia J. Paoletti E. Poxvirus recombinants as live vaccines Binns M.M. Smith G.L. Recombinant Poxviruses 1992 CRC Press Boca Raton, FL 123 162
13. Davison A.J. Moss B. New vaccinia virus recombination plasmids incorporating a synthetic late promoter for high level expression of foreign proteins Nucleic Acids Res 18 1990 4285 4286
14. Earl P.L. Moss B. Protein expression IV: Expression of proteins in mammalian cells using vaccinia Ausubel F.M. Brent R. Kingston R.E. Current Protocols in Molecular Biology 1991 Green Publishing Associates and Wiley-Interscience New York 16.15.1-16.18.10
15. Goebel S.J. Johnson G.P. Perkus M.E. The complete DNA sequence of vaccinia virus Virology 179 1990 247 266
16. Graham B.S. Matthews T.J. Belahe R.B. Augmentation of human immunodeficiency virus type I neutralizing antibody by priming with gp 160 recombinant vaccinia and boosting with rgp 160 in vaccinia-naive adults J Infect Dis 167 1993 533 537
17. Lee S.S. Eisenlohr L.C. McCue P.A. Intravenical gene therapy: In vivo gene transfer using recombinant vaccinia virus vectors Cancer Res 54 1994 3325 3328
18. Mackett M. Smith G.L. Moss B. Vacinnia Virus: A selectable eukaryotic cleaning and expression vector Proc Natl Acad Sci U S A 79 1982 7415 7419
19. Meko J.B. Yim J.H. Tsung K. High cytokine production and effective anti-tumor activity of recombinant vaccinia virus encoding murine IL-12 Cancer Res 55 1995 4765 4770
20. Moss B. Poxvirus vectors: Cytoplasmic expression of transferred genes Cur Opin Genet Dev 3 1993 86 90
21. Moss B. Vaccinia virus: A tool for research and vaccine development Sci 252 1991 1662 1667
22. Neff J.M. Lane J.M. Pert J.H. Complications of smallpox vaccination N Engl J Med 76 1967 125 132
23. Norton J.A. Peplinski G.R. Tsung K. Expression of secret platelet-derived growth factor-B by recombinant nonreplicating and noncytopathic vaccinia virus Ann Surg 224 1996 555 560
24. Panicali D. Paoletti E. Construction of poxviruses as cloning vectors: Insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus Proc Natl Acad Sci USA 79 1982 4927 4931
25. Peplinski G.R. Tsung K. Casey M.J. In vivo murine tumor gene delivery and expression by systemic recombinant vaccinia virus encoding interleukin-1 beta Cancer Journal Scientific America 2 1996 21 27
26. Peplinski G.R. Tsung K. Meko J.B. Prevention of murine pancreas tumor with recombinant vaccinia virus encoding human interleukin-1 beta Surgery 118 1995 185 191
27. Peplinski G.R. Tsung K. Meko J.B. Prevention of murine breast cancer by vaccination with tumor cells modified by cytokine-producing recombinant vaccinia viruses Ann Surg Oncol 3 1996 15 23
28. Peplinski G.R. Tsung K. Whitman E.D. Construction and expression in tumor cells of a recombinant vaccinia virus encoding human interleukin-1 B Ann Surg Oncol 2 1995 151 159
29. Smith G.L. Moss B. Infectious poxvirus vectors have capacity for at least 25,000 base pairs of foreign DNA Gene 25 1983 21 28
30. Tartaglia J. Perkus M.E. Taylor J. NYVAC: A highly attenuated strain of vaccinia virus Virology 188 1992 217 232
31. Tsung K. Meko J.B. Peplinski G.R. Interleukin-12 induces a Thl-directed antitumor response J Immunol 158 1997 3359 3365
32. Tsung K. Yim J.M. Marti W. Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light J Virol 70 1996 165 171
33. Wilson J.M. Vehicles for gene therapy Nature 365 1993 691 692